StockData

Yubo International Biotech Ltd (YBGJ) stock

YBGJOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$0.01+0.00 (0.00%)

Close on Oct 16, 2026Market cap $886.19KP/E –Yield –

Yubo International Biotech profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Yubo International Biotech's profit margin for the twelve months ending Jun 30, 2026 was -8157.3%. For fiscal 2026 it was -8736.7%, against -51171.4% the year before. The highest annual figure on record is -124.0% in fiscal 2022.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2026Dec 31, 2025-8736.7%+42434.7
FY2025Dec 31, 2024-51171.4%−50973.8
FY2024Dec 31, 2023-197.6%+957.9
FY2023Dec 31, 2022-1155.5%−1031.6
FY2022Dec 31, 2021-124.0%–

Quarterly profit margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q4 FY2026CQ4 2025Dec 31, 2025-1432.5%+24254.7
Q1 FY2025CQ1 2024Mar 31, 2024-10817.0%−10614.8
Q4 FY2024CQ4 2023Dec 31, 2023-2321.6%−2477.3
Q3 FY2024CQ3 2023Sep 30, 20231.5%+1634.5
Q2 FY2024CQ2 2023Jun 30, 2023-25687.2%−19519.6
Q1 FY2024CQ1 2023Mar 31, 2023-202.2%+3603.4
Q4 FY2023CQ4 2022Dec 31, 2022155.8%+275.3
Q3 FY2023CQ3 2022Sep 30, 2022-1633.0%−1290.6
Q2 FY2023CQ2 2022Jun 30, 2022-6167.6%–
Q1 FY2023CQ1 2022Mar 31, 2022-3805.6%–
Q4 FY2022CQ4 2021Dec 31, 2021-119.5%–
Q3 FY2022CQ3 2021Sep 30, 2021-342.4%–

More Yubo International Biotech figures

See a number that looks wrong?